Printer Friendly

TELIOS ANNOUNCES NORSK HYDRO DECISION

 SAN DIEGO, Jan. 15 /PRNewswire/ -- Telios Pharmaceuticals, Inc. (NASDAQ: TLIO) announced today that it will reacquire entire ownership of Telios Pharma GmbH and its products in Europe as a result of the decision of Norsk Hydro a.s ("Norsk") not to exercise its right to purchase 806,331 shares of Telios Common Stock for $7.5 million at an average price of $9.30 per share.
 Norsk indicated that its decision, notwithstanding positive aspects of recent clinical trials of Telio-Derm(R), was based upon its view that the development of Telio-Derm(R) for Europe would take longer and cost more than it had anticipated when it considered its initial investment in 1990.
 Norsk has also informed the Company that it would exercise its right to withdraw from Telios Pharma GmbH, a German limited liability company formed for the purpose of developing and marketing Telios products in Europe and owned 55 percent by Norsk and 45 percent by Telios. Norsk indicated that it would assign its ownership interest in Telios Pharma GmbH to Telios.
 Dr. Robert J. Erickson, Ph.D., President and Chief Executive Officer of Telios said, "This decision by Norsk Hydro will allow us to pursue new opportunities in our world-wide licensing and commercialization strategies."
 Telios is developing a new class of therapeutic products based upon research into the role of the extracellular matrix. Telios is applying its proprietary technology to develop products for the treatment of severe and chronic dermal wounds, ophthalmic wounds, fibrotic diseases, cardiovascular diseases, and osteoporosis. Telios is currently in clinical trials with two novel peptide-based products, Telio-Derm(R), a treatment designed to accelerate healing of severe and chronic dermal wounds, and OcuNex(TM) and ophthalmic wound healing product.
 -0- 1/15/93
 /CONTACT: Audrey D. Keane, Director of Corporate Development of Telios Pharmaceuticals, Inc., 619-622-2615/
 (TLIO)


CO: Telios Pharmaceuticals, Inc.; Telios Pharma GmbH; Norsk Hydro
 a.s. ST: California IN: MTC SU:


KJ -- SD003 -- 5617 01/15/93 20:14 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 15, 1993
Words:327
Previous Article:WESTCO BANCORP, INC. REPORTS FOURTH QUARTER EARNINGS
Next Article:AAA PRESENTS CLINTON WITH TRIPTIK ROUTING FOR INAUGURAL BUS TRIP
Topics:


Related Articles
MOBIL TO SELL NORWEGIAN GASOLINE, HEATING FUELS BUSINESS
TELIOS REDUCES WORK FORCE
TELIOS AMENDS AND RESUBMITS PMA FOR ARGIDENE(TM) Gel
Standard & Poor's Puts Saga on Watch; Norsk Hydro Makes Bid for Saga.
Hydro's Corporate Assembly Recommends Agri Demerger.
Hydro Chairperson Egil Myklebust to Step Down in 2004.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters